extract
echinacea
speci
use
tradit
north
america
control
symptom
cold
influenza
diseas
becom
popular
herbal
medicin
recent
studi
reveal
prepar
deriv
certain
speci
plant
part
possess
potent
antivir
activ
noncytotox
concentr
particularli
membranecontain
virus
thu
strain
human
avian
influenza
virus
test
includ
tamifluresist
strain
well
herp
simplex
viru
respiratori
syncyti
viru
rhinovirus
sensit
standard
echinacea
purpurea
prepar
mechanist
studi
influenza
virusspecif
hemagglutinin
neuraminidas
inhibit
addit
extract
display
antiinflammatori
activ
virusinfect
cell
numer
effect
express
cellular
gene
multipl
compon
either
discret
compound
mixtur
appear
respons
variou
antivir
activ
acut
respiratori
infect
human
usual
ascrib
one
group
well
known
virus
includ
rhinovirus
common
cold
virus
influenza
virus
b
parainfluenza
virus
corona
virus
respiratori
syncyti
viru
certain
adenovirus
addit
recent
applic
sensit
molecular
detect
techniqu
reveal
presenc
virus
metapneumovirus
bocavirus
might
also
involv
gener
respiratori
symptom
howev
know
newli
recogn
virus
realli
pathogen
simpli
passeng
elud
previou
diagnost
techniqu
nevertheless
variou
famili
virus
differ
structur
replic
scheme
consequ
bear
differ
potenti
molecular
target
clearli
involv
respiratori
symptom
indic
tabl
among
possibl
target
virion
ii
cellular
attach
entri
iii
one
mani
stage
viru
replic
develop
particularli
involv
virusspecif
enzym
iv
egress
progeni
viru
infect
cell
howev
varieti
replic
scheme
indic
tabl
reduc
chanc
singl
antivir
drug
could
target
mani
virus
addit
major
respiratori
infect
specif
viru
inform
lack
consequ
difficult
conceiv
singl
therapeut
agent
regimen
could
control
caus
agent
nevertheless
spite
limit
consider
time
money
spent
tri
find
silver
bullet
specif
viru
infect
far
without
much
success
anoth
problem
specif
target
approach
especi
case
compound
direct
specif
viral
gene
product
inevit
emerg
viru
resist
mutant
subsequ
spread
commun
environ
convent
answer
problem
suggest
two
antivir
drug
distinct
molecular
target
use
combin
notwithstand
like
increas
undesir
sideeffect
logic
altern
approach
use
nontox
agent
capac
inhibit
mani
differ
respiratori
virus
simultan
recent
evid
indic
certain
herbal
extract
might
fulfil
requir
cold
flu
term
coin
describ
combin
common
symptom
supposedli
brought
action
specif
viral
infect
upper
respiratori
tract
symptom
may
includ
familiar
discomfort
sneez
stuffi
nose
irrit
mucou
membran
excess
mucu
product
sinus
cough
sore
throat
malais
fever
well
exacerb
asthma
copd
chronic
obstruct
pulmonari
diseas
case
symptom
may
spread
includ
lower
respiratori
tract
lung
result
bronchiti
bronchiol
pneumonia
howev
symptom
may
direct
result
viru
replic
mani
case
minim
airway
tissu
rather
indirect
consequ
virusinduc
inflammatori
respons
respiratori
infect
whether
start
nasal
passag
oropharynx
part
airway
invad
viru
initi
encount
epitheli
tissu
compos
larg
epitheli
cell
occasion
dendrit
cell
macrophag
accordingli
respond
mean
variou
antimicrobi
strategi
make
innat
immun
system
includ
defens
peptid
antimicrobi
peptid
secret
variou
proinflammatori
cytokin
mediat
inflamm
molecul
kinin
releas
probabl
respons
earli
symptom
phagocyt
cell
variou
type
inflammatori
cell
may
attract
site
infect
addit
redox
balanc
cell
may
advers
affect
either
viru
infect
consequ
proinflammatori
respons
sinc
symptom
reflect
common
nonspecif
host
respons
infect
agent
rather
direct
cytolyt
cytopath
effect
specif
viru
ration
therapeut
approach
would
applic
antiinflammatori
agent
especi
intent
therapi
amelior
symptom
potenti
safe
antiinflammatori
agent
also
contain
multipl
antivir
activ
would
provid
bonu
limit
convent
antivir
therapi
prevent
illustr
sudden
appear
sar
sever
acut
respiratori
syndrom
pandem
novel
coronaviru
respons
diseas
sarscov
quickli
isol
genom
sequenc
howev
adequ
antivir
treatment
deem
avail
time
sever
herbal
extract
shown
recent
possess
combin
bioactiv
could
use
control
cold
flu
bronchiti
retrospect
could
use
sar
patient
among
herbal
prepar
echinacea
extract
becom
popular
although
necessarili
benefici
discuss
herbal
prepar
echinacea
usual
made
form
extract
tinctur
tea
spray
etc
deriv
variou
part
one
three
speci
echinacea
e
purpurea
e
angustifolia
e
pallida
tabl
ref
speci
receiv
less
attent
howev
problem
commerci
echinacea
extract
gener
common
mani
herbal
product
inadequ
character
standard
consequ
differ
commerci
sourc
deriv
differ
speci
plant
part
result
distinct
chemic
composit
may
show
differ
combin
bioactiv
case
rel
littl
bioactiv
result
research
studi
especi
clinic
studi
yield
inconsist
result
also
import
ensur
antivir
activ
detect
herbal
prepar
realli
signific
say
extract
abl
inactiv
substanti
amount
viru
practic
noncytotox
dosag
therefor
assay
techniqu
reflect
requir
earli
report
antivir
activ
echinacea
indic
sever
differ
methanol
aqueou
extract
deriv
e
purpurea
could
partial
protect
cultur
cell
infect
influenza
viru
herp
simplex
viru
type
vesicular
stomat
virus
suggest
intracellular
inhibit
although
possibl
virucid
activ
report
later
studi
support
concept
echinacea
speci
potenti
sourc
antivir
activ
cheminat
et
al
isol
character
group
caffeoyl
deriv
dri
fresh
e
pallida
plant
examin
two
cichor
acid
echinacosid
well
caffeic
acid
constitu
e
purpurea
activ
replic
vesicular
stomat
viru
membran
contain
rna
viru
mous
cell
line
activ
rel
weak
howev
except
high
cytotox
concentr
possibl
virucid
activ
test
binn
et
al
examin
extract
varieti
differ
speci
plant
part
antivir
activ
herp
simplex
viru
assay
design
test
virucid
activ
viral
growth
inhibit
also
incorpor
exposur
light
case
photosensit
involv
often
found
bioactiv
constitu
medicin
plant
ref
result
summar
tabl
mani
extract
show
signific
rel
weak
activ
although
hexan
root
extract
e
purpurea
ethanol
infloresc
extract
e
sanguinea
substanti
pure
cichor
acid
also
moder
activ
could
therefor
contribut
activ
certain
extract
weak
activ
vimalanathan
et
al
tabl
ref
evalu
differ
solvent
fraction
e
purpurea
aerial
part
activ
sever
virus
presenc
absenc
light
reaction
aqueou
extract
activ
herp
simplex
viru
influenza
viru
activ
depend
light
exposur
contrast
ethyl
acet
fraction
ethanol
extract
contain
impress
activ
virus
due
photosent
activ
rhinoviru
detect
polysaccharideenrich
fraction
also
test
found
contain
rel
weak
activ
data
summar
form
mic
minimum
inhibitori
concentr
tabl
similar
studi
carri
compar
root
extract
e
purpurea
e
angustifolia
e
pallida
aqueou
fraction
e
purpurea
root
almost
devoid
caffeic
acid
deriv
alkylamid
show
impress
activ
hsv
influenza
viru
tabl
e
angustifolia
root
extract
contain
moder
activ
three
virus
hsv
influenza
rhinoviru
ethyl
acet
fraction
activ
aqueou
extract
contrast
e
pallida
root
extract
devoid
antivir
activ
howev
recent
studi
seri
aqueou
ethanol
extract
e
pallida
aerial
part
show
signific
virucid
activ
extract
also
appear
inhibit
viru
replic
within
infect
cell
differ
extract
distinct
chemic
profil
expect
author
conclud
combin
compon
rather
individu
compound
respons
differ
activ
recent
test
found
ethanol
extract
e
angustifolia
aerial
part
activ
hsv
correspond
e
purpurea
extract
unpublish
observ
thu
indic
may
similar
antivir
compound
aerial
part
extract
three
common
echinacea
speci
e
purpurea
e
angustifolia
e
pallida
also
clear
sever
differ
compound
contribut
overal
antivir
activ
given
extract
although
mani
extract
devoid
activ
presenc
multipl
antivir
activ
among
differ
extract
fraction
suggest
mani
kind
echinacea
prepar
tinctur
spray
tablet
tea
etc
could
benefici
treatment
cold
flu
although
prepar
like
effect
fact
recent
studi
commerci
prepar
highlight
variabl
antivir
activ
differ
prepar
although
lottolot
variat
less
evid
gener
ethanol
base
extract
greater
antivir
activ
aqueou
extract
possibl
identifi
specif
compon
respons
activ
furthermor
correl
antivir
activ
antiinflammatori
activ
recent
detail
studi
standard
prepar
echinaforc
compris
ethanol
extract
e
purpurea
aerial
part
plu
root
abbrevi
ef
show
prepar
activ
virucid
agent
virus
membran
indic
tabl
addit
respiratori
syncyti
viru
test
human
avian
strain
influenza
viru
well
influenza
b
viru
suscept
addit
rhinoviru
also
equal
suscept
rel
high
concentr
echinaforc
recommend
oral
consumpt
dilut
equival
mgml
dri
weightvolum
condit
infecti
virus
could
kill
within
min
contrast
echinaforc
found
less
effect
intracellular
viru
consequ
viru
alreadi
present
within
cell
could
refractori
inhibitori
effect
echinaforc
viru
particl
shed
extracellular
fluid
would
vulner
therefor
action
echinaforc
would
manifest
initi
contact
viru
ie
incept
infect
also
transmiss
viru
infect
cell
addit
experi
show
continu
passag
influenza
viru
cell
cultur
presenc
echinaforc
result
emerg
resist
strain
wherea
passag
viru
success
cultur
presenc
tamiflu
rapidli
gener
tamifluresist
furthermor
tamifluresist
viru
remain
fulli
suscept
echinaforc
therefor
continu
usag
echinaforc
popul
would
less
like
gener
resist
strain
viru
tamiflu
antiinfluenza
compound
current
market
recent
studi
illustr
rel
eas
resist
strain
influenza
viru
aris
furthermor
echinaforc
could
also
use
accessori
treatment
individu
undergo
antiinfluenza
therapi
agent
tamiflu
shown
hemagglutin
assay
extract
ef
inhibit
receptor
bind
activ
influenza
virus
rang
ef
concentr
includ
recommend
oral
consumpt
suggest
ef
interf
viral
entri
cell
thu
effect
render
viru
noninfecti
ef
also
inhibit
neuraminidas
activ
vitro
unpublish
result
suggest
activ
compound
could
block
influenza
viru
entri
spread
act
least
two
virion
target
howev
suscept
virus
reli
ha
na
function
echinaforc
indic
addit
molecular
target
must
access
suffer
cold
respiratori
problem
would
agre
secret
excess
mucu
one
annoy
symptom
accordingli
mani
pharmaceut
design
reliev
featur
cold
flu
usual
accompani
undesir
side
effect
rhinovirus
induc
secret
excess
domin
respiratori
mucin
bronchial
epitheli
cell
cultur
cultur
airway
tissu
echinaforc
revers
secret
system
suggest
could
addit
benefit
echinacea
treatment
result
support
histochem
examin
cultur
airway
tissu
reveal
conspicu
presenc
mucopolysaccharidefil
goblet
cell
result
rhinoviru
infect
wherea
ef
treat
infect
tissu
appear
normal
seri
studi
sharma
et
al
focus
applic
e
purpurea
extract
includ
echinaforc
epitheli
cell
tissu
infect
virus
rhinoviru
infect
human
bronchial
lung
epitheli
cell
line
viru
could
stimul
secret
differ
cytokin
includ
proinflammatori
known
collect
involv
mani
symptom
common
cold
flu
sneez
fever
sore
throat
nasal
discharg
inflamm
variou
respiratori
tissu
certain
echinacea
prepar
abl
complet
partli
revers
stimul
studi
echinaforc
shown
ef
could
ad
viru
infect
similar
success
also
result
affect
viru
dose
time
exposur
ef
virus
includ
influenza
viru
adenoviru
type
respiratori
syncyti
viru
stimul
secret
proinflammatori
cytokin
case
stimul
revers
ef
tabl
ref
howev
live
infecti
virus
abl
infect
equival
dose
ultravioletinactiv
virus
fail
elicit
respons
suggest
viru
may
enter
cell
undergo
degre
gene
express
order
stimul
cytokin
express
secret
also
interest
virus
adenovirus
vulner
direct
attack
echinacea
could
nevertheless
stimul
cytokin
secret
still
suscept
cytokin
revers
attempt
correl
immun
modulatori
effect
specif
class
echinacea
compon
variou
chemic
character
extract
fraction
deriv
three
common
speci
echinacea
evalu
possibl
inhibitori
effect
secret
proinflammatori
cytokin
human
bronchial
epitheli
cell
infect
rhinoviru
type
e
purpurea
fraction
compris
aqueou
ethanol
extract
root
leav
stem
lesser
degre
flower
strongli
inhibit
secret
cytokin
result
suggest
differ
compound
combin
respons
antivir
antiinflammatori
effect
sever
studi
report
effect
echinacea
prepar
cellular
gene
express
mostli
uninfect
cultur
cell
relev
immun
system
although
feasibl
compar
studi
differ
cellular
system
echinacea
prepar
differ
randolph
et
al
describ
chang
level
express
term
mrna
protein
sever
cytokin
gene
human
blood
sampl
taken
differ
time
treatment
commerci
blend
echinacea
product
brovelli
et
al
found
express
sever
cytokin
gene
cultur
human
monocyt
influenc
natur
echinacea
prepar
stage
develop
plant
part
use
presum
reflect
differ
chemic
composit
altamiranodima
et
al
analyz
gene
express
human
bronchial
cell
mean
dna
microarray
follow
treatment
one
two
e
purpurea
prepar
polysaccharid
rich
aqueou
extract
alkylamiderich
ethanol
extract
without
infect
rhinoviru
type
extract
influenc
express
mani
gene
includ
cytokin
gene
although
pattern
express
differ
two
extract
addit
viru
induc
numer
chang
mostli
increas
express
extract
tend
decreas
ie
restor
normal
level
express
level
analysi
effect
reveal
chang
cytokin
express
interconnect
specif
transcript
factor
cebpb
caatenhancerbind
protein
b
sinc
sharma
et
al
shown
numer
transcript
factor
affect
e
purpurea
extract
cellviru
system
tempt
conclud
mani
gene
express
effect
echinacea
extract
could
due
chang
express
activ
statu
multipl
transcript
factor
turn
could
brought
interact
surfac
receptor
intracellular
modul
howev
extens
analys
altamiranodima
et
al
use
cytokin
array
cytokin
chemokin
observ
chang
cellular
gene
express
cytokin
appar
reflect
correspond
protein
express
thu
interact
particular
echinacea
extract
target
cell
infect
otherwis
complex
may
involv
differ
level
signal
pathway
network
nevertheless
import
conclus
analys
rhinoviru
induct
numer
cytokin
secret
modul
appropri
echinacea
purpurea
extract
wang
et
al
describ
effect
butanol
fraction
deriv
aerial
part
e
purpurea
gene
express
immunerel
molecul
human
dendrit
cell
part
adapt
immun
respons
contrast
studi
describ
focus
innat
immun
respons
mani
dendrit
cell
gene
affect
either
regul
downregul
studi
includ
infect
cell
clearli
show
multipl
gene
effect
echinacea
prepar
benson
et
al
studi
effect
extract
e
purpurea
aqueou
extract
root
ethanol
extract
aerial
part
select
immunerel
protein
murin
dendrit
cell
found
varieti
signific
respons
reinforc
concept
multipl
consequ
echinacea
exposur
immunolog
import
cell
result
review
indic
certain
echinacea
extract
contain
multipl
bioactiv
collect
inactiv
andor
inhibit
mani
virus
differ
level
influenza
virus
present
least
two
molecular
target
hemagglutinin
neuraminidas
protein
virus
evid
contain
addit
virion
target
also
intracellular
mechan
play
includ
widespread
revers
virusinduc
proinflammatori
cytokin
secret
mediat
one
signal
pathway
event
occur
noncytotox
concentr
lack
correl
antivir
activ
presenc
known
marker
compound
echinacea
extract
ie
caffeic
acid
deriv
alkylamid
certain
type
polysaccharid
prompt
us
search
evid
altern
bioactiv
compound
found
recent
antivir
activ
ethanol
extract
e
purpurea
aerial
part
abl
bind
polymer
matrix
polyvinylpolypyrrolidon
pvpp
could
subsequ
elut
recov
hudson
vimalanathan
unpublish
result
recent
studi
pvpp
shown
effect
select
remov
tannin
polyphenol
plant
extract
varieti
chemic
interact
thu
antivir
compon
e
purpurea
aerial
part
could
could
includ
polyphenol
antiinflammatori
activ
could
due
partli
alkylamid
constitu
view
numer
effect
echinacea
extract
gene
express
addit
consequ
anticip
could
also
supplement
benefici
effect
echinacea
counteract
viru
infect
activ
compound
isol
character
analys
could
lead
improv
efficaci
extract
addit
provid
evid
substanti
medic
claim
made
echinacea
studi
echinacea
extract
shown
possess
multipl
benefici
action
treatment
viral
respiratori
infect
direct
virucid
activ
sever
respiratori
virus
revers
proinflammatori
respons
epitheli
cell
tissu
differ
virus
reduct
excess
secret
mucin
airway
cell
tissu
lack
cytotox
effect
disrupt
tissu
integr
echinacea
airway
cell
cultur
tissu
practic
antivir
concentr
addit
potenti
posit
effect
cellular
gene
express
combin
benefici
activ
could
reduc
amount
prevail
viabl
viru
transmiss
also
lead
amelior
virusinduc
symptom
